American Century Companies Inc. purchased a new stake in Henry Schein, Inc. (NASDAQ:HSIC) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 963,742 shares of the company’s stock, valued at approximately $67,346,000.

Several other institutional investors have also recently modified their holdings of the company. Thrivent Financial For Lutherans lifted its holdings in shares of Henry Schein by 3.8% in the second quarter. Thrivent Financial For Lutherans now owns 3,000 shares of the company’s stock valued at $549,000 after purchasing an additional 110 shares in the last quarter. Colony Group LLC lifted its holdings in shares of Henry Schein by 1.3% in the second quarter. Colony Group LLC now owns 12,734 shares of the company’s stock valued at $2,331,000 after purchasing an additional 158 shares in the last quarter. QS Investors LLC lifted its holdings in shares of Henry Schein by 9.6% in the second quarter. QS Investors LLC now owns 4,225 shares of the company’s stock valued at $773,000 after purchasing an additional 369 shares in the last quarter. Trust Co. of Vermont lifted its holdings in shares of Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock valued at $140,000 after purchasing an additional 616 shares in the last quarter. Finally, FTB Advisors Inc. lifted its holdings in shares of Henry Schein by 100.0% in the third quarter. FTB Advisors Inc. now owns 1,484 shares of the company’s stock valued at $120,000 after purchasing an additional 742 shares in the last quarter. Institutional investors own 90.93% of the company’s stock.

Shares of Henry Schein, Inc. (HSIC) opened at $71.75 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $11,400.00, a PE ratio of 20.68, a P/E/G ratio of 1.82 and a beta of 1.00. Henry Schein, Inc. has a 12-month low of $65.28 and a 12-month high of $93.50.

HSIC has been the topic of a number of research reports. Robert W. Baird set a $95.00 price target on Henry Schein and gave the company a “buy” rating in a report on Thursday, October 19th. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, November 13th. Stifel Nicolaus cut their price target on Henry Schein from $89.00 to $77.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Craig Hallum upgraded Henry Schein from a “hold” rating to a “buy” rating in a report on Tuesday, November 7th. Finally, Evercore ISI started coverage on Henry Schein in a report on Thursday, January 4th. They issued an “outperform” rating and a $81.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $84.23.

In related news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total value of $410,124.96. Following the sale, the director now owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.19% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “American Century Companies Inc. Purchases Shares of 963,742 Henry Schein, Inc. (HSIC)” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://theolympiareport.com/2018/02/11/american-century-companies-inc-purchases-shares-of-963742-henry-schein-inc-hsic.html.

Henry Schein Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.